BLND
Blend Labs, Inc.
BLND's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over BLND overall, supported by stronger valuation and stronger fundamentals.
BLND Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Unavailable |
BLND's cash flow is currently healthy, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BLND PE Valuation
BLND has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
BLND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BLND's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
BLND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.04 | — |
| Q3 2024 | -$0.33 | +$0.64 |
| Q2 2024 | -$0.48 | +$0.88 |
| Q1 2024 | -$0.57 | +$2.67 |
| Q4 2023 | -$0.76 | +$2.52 |
NVDA has the stronger earnings trend. Trailing diluted EPS is down 116% for BLND versus NVDA up 125%.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
BLND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | +0.2% |
| Q2 2026 | $33.8M | +7.3% |
| Q1 2026 | $30.8M | +15% |
| Q4 2025 | $32.4M | -22% |
| Q3 2025 | $32.9M | -27% |
| Q2 2025 | $31.5M | -22% |
| Q1 2025 | $26.8M | -23% |
| Q4 2024 | $41.4M | +15% |
BLND's revenue fell from its 2021 peak and has held roughly level since: $33M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +6.9 points |
| Q2 2026 | -4.7% | +10 points |
| Q1 2026 | -16% | +12 points |
| Q4 2025 | -11% | -6.7 points |
| Q3 2025 | -15% | +15 points |
| Q2 2025 | -15% | +18 points |
| Q1 2025 | -29% | +32 points |
| Q4 2024 | -4.3% | +56 points |
BLND's operating margin was −8% last quarter, up 6.9 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over BLND on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over BLND on profitability, with a higher operating margin.
BLND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94K | +$5.9M |
| Q2 2026 | $7.1M | +$17.2M |
| Q1 2026 | $6.2M | -61% |
| Q4 2025 | -$21K | +$7.1M |
| Q3 2025 | -$5.8M | -$4.4M |
| Q2 2025 | -$10.1M | -$1.6M |
| Q1 2025 | $15.8M | +$21.6M |
| Q4 2024 | -$7.2M | +$13.6M |
BLND's free cash flow has turned positive after six years mostly in the red: $13M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over BLND on cash flow, with more consistent year-over-year improvement.
BLND Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.2% | -18.3M shares |
| 1 year | -8.4% | -21.9M shares |
| 3 years | -2.8% | -6.9M shares |
| 5 years | +8.1% | +17.7M shares |
| Available history | +8.1% | +17.7M shares |
BLND has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $20.4M |
| Q1 2026 | $16.8M |
| Q4 2025 | $15.7M |
| Q3 2025 | $5M |
| Q2 2025 | $1.6M |
| Q1 2025 | $2.6M |
| Q4 2021 | $110,000 |
BLND spent $53M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BLND Net Leverage
BLND's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BLND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 19.4 | Oversold |
BLND's weekly RSI is 38 (neutral) and its Stochastic is 19 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BLND PE vs Technology Sector
BLND has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
BLND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 1.9% above |
| 20 week MA | $1.37 | 22% below |
| 50 week MA | $1.77 | 40% below |
| 100 week MA | $2.63 | 59% below |
| 200 week MA | $2.44 | 56% below |
BLND has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 56% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BLND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.9 | $7.53 | -64% |
| 2022 | $7.53 | $1.22 | -84% |
| 2023 | $1.22 | $2.55 | +109% |
| 2024 | $2.55 | $4.29 | +68% |
| 2025 | $4.29 | $3.05 | -29% |
| 2026 YTD | $3.05 | $1.07 | -65% |
BLND's yearly returns have swung widely, from +109% in 2023 to −84% in 2022. It's down 65% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over BLND on returns for 2026, with the stronger performance.